StockData
NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

NUTRA PHARMA CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.00+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$806.69K
P/E (TTM)
–
Dividend yield
–

NUTRA PHARMA CORP revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Nutra Pharma does not break out revenue by segment, region or product in the tagged data of its filings for this period type.